CDC Advisors Endorse Maternal RSV Vax to Protect Newborns
The CDC’s advisors on Friday recommended a maternal respiratory syncytial virus (RSV) vaccine to protect infants from serious infections. By an 11-1 vote, the Advisory Committee on Immunization Practices (ACIP) recommended that pregnant women receive a single dose of Pfizer’s prefusion F protein (RSVpreF) vaccine (Abrysvo) at 32 to 36 weeks’ gestation to prevent lower […]
FDA Approves RSV Vaccine For Moms-To-Be To Guard Their Newborns
LOADINGERROR LOADING WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is notorious for filling hospitals with wheezing babies every fall and winter. The Food and Drug Administration cleared Pfizer’s maternal vaccination to guard against […]
When Is It Considered Too Late To Get The HPV Vaccine?
Fly View Productions via Getty Images The HPV vaccine can protect against high-risk strains of the human papillomavirus, which can cause cancer. Human papillomavirus, or HPV, is a group of more than 200 related viruses that are spread by skin-to-skin and sexual contact. Not only is it the most common sexually transmitted infection in the […]
Second RSV Vaccine Lands Approval for Older Adults
The FDA has approved a second respiratory syncytial virus (RSV) vaccine for preventing lower respiratory infections in adults 60 and over, Pfizer announced on Wednesday. Approval of the unadjuvanted, bivalent RSV prefusion F protein vaccine (Abrysvo) follows an endorsement in March from FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC). Advisors voted 7-4 in […]
Safety Data on Maternal RSV Vaccine ‘Favorable,’ FDA Staff Says
A maternal respiratory syncytial virus (RSV) vaccine candidate prevents infections in infants and comes with “generally favorable” safety data, said FDA staff in briefing documents released ahead of an advisory committee meeting this week, but the reviewers “noted potential uncertainty based on the numerical imbalance in premature deliveries.” On Thursday, members of the Vaccines and […]
Sublingual Vaccine Shows Promise in Women With Recurrent UTIs
CHICAGO — A sublingual vaccine not only reduced the risk of recurrent urinary tract infections (UTIs) in women, it also appeared to enable a significant number of these women to be completely UTI-free, according to a North American study. Among 67 women with three or more UTIs per year, 40.6% of those receiving a 3-month […]
FDA Allows Extra Doses of Bivalent COVID Vax for Immunocompromised Tots
The FDA has authorized additional doses of Pfizer/BioNTech’s bivalent COVID-19 vaccine for young immunocompromised children, the agency announced on Friday. In kids ages 6 months to 4 years with certain types of immunocompromising conditions (i.e., solid-organ transplant recipients, or those considered to have a similar level of immunocompromise), and who previously received three primary 0.2-mL […]
Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanoma
ORLANDO — Adding a personalized cancer vaccine to anti-PD-1 immunotherapy for resectable melanoma led to a 44% improvement in recurrence-free survival (RFS) versus immunotherapy alone, according to a study reported here. Patients who received the mRNA vaccine, derived from their own tumor, had an 18-month RFS of 78.6% as compared with 62.2% for patients who […]
Opinion | Nobody Wants This Job. Should Physicians Stick Around?
As I enter the patient exam room, the first question is no longer, “When can I get my COVID-19 vaccine?” but rather, “Are you leaving? My old doctor left. You are my fifth doctor in 3 years. What is happening?” Nowadays, I spend more time educating patients about the visible cracks our medical system flaunts. […]
FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates
Ahead of a 2-day meeting with FDA’s vaccine advisors, reviewers at the agency highlighted a rare but potential risk for Guillain-Barré syndrome with two vaccine candidates for respiratory syncytial virus (RSV). On Tuesday and Wednesday, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) will recommend whether the risk-benefit profile with Pfizer and GSK’s vaccine […]